Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03669731
Other study ID # CHU-405
Secondary ID 2017-A02350-53
Status Recruiting
Phase N/A
First received
Last updated
Start date October 10, 2018
Est. completion date March 30, 2020

Study information

Verified date February 2019
Source University Hospital, Clermont-Ferrand
Contact Lise LACLAUTRE
Phone 04 73 75 49 63
Email drci@chu-clermontferrand.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Adequate equipment for lifelong health is essential to ensure healthy health for fetal development. In France, pregnant women with normal weight have increased protein intake to 0.78-0.95g / kg / day (ANC 2001). And more recently, AFSSA from 2007 proposed a recommended nutritional intake of 0.82-1g / kg / d. An increased requirements in the second and third trimester of 0.25 g / kg / day and 0.46 g / kg / day, respectively, compared with non-pregnancy values. However, the prevalence of the incompatibility remains unknown.

In addition, maternal protein intake is inadequate or excessively associated with both intra-uterine growth retardation and small gestational age weights. Neonatal hypotrophy is also associated with a risk of chronic diseases in adulthood, including cardiovascular disease, type 2 diabetes, insulin resistance, high blood pressure and coronary heart disease.

In obese women or patients undergoing surgery for bariatric surgery, there is currently no recommendation on the recommended protein intake. Or, maternal obesity plays a role in the metabolic development of children and bariatric surgery is associated with a major risk of maternal micronutrient deficiencies and intra-uterine growth retardation.

Prevalence of obesity in France is currently estimated at 17%. Moreover, bariatric surgery is also fast-growing in France with a number of interventions having tripled since 2006.

Thus, a better understanding of maternal food needs and applications throughout pregnancy is needed to improve dietary guidelines and promote fetal, neonatal and long-term health.


Description:

The main objective is to evaluate the protein intake of the pregnant woman in the 3rd trimester of pregnancy in 3 populations:

- Women with BMI ≥ 18.5 and <30 kg / m² (group 1)

- Obese women (BMI ≥ 30 kg / m²) (group 2)

- Women operated on a bariatric surgery (group 3)


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date March 30, 2020
Est. primary completion date June 30, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- - Pregnant women from 20 amenorrhea weeks.

- Women aged at least 18 years old.

- Women with BMI = 18.5 and <30 kg / m² = Group 1

- Obese women (BMI = 30 kg / m²) = Group 2

- Women operated on a bariatric surgery (by-pass, sleeve-gastrectomy, gastric band) = Group 3

Exclusion Criteria:

- - Women with BMI <18.5 kg / m²

- Troubles of eating behavior

- Women with gestational diabetes

- Medical history of type 1 or type 2 diabetes

- Multiple pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
food diary
This food diary is to be completed by the patient in the 3rd trimester of pregnancy, on 3 consecutive days and if possible including a weekend day. Finally, the investigator also prescribes a biological analysis: a urinary urea from a 24h diuresis to be collected in the 3rd trimester in a dedicated collector and given that same day.

Locations

Country Name City State
France Chu Clermont-Ferrand Clermont-Ferrand

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Protein intake In the 3rd trimester = Weight adjusted protein intake (g / kg / day) ± total protein intake (g / d) and protein proportion of total caloric intake (%) using a 3-day diary. an average of 33 weeks
Secondary link between protein consumption in the 3rd trimester and ultrasound data For the 3 groups: results of all obstetrical ultrasound exams performed at 20 AS an average of 33 weeks
Secondary nutritional state (nutritional deficiencies) of pregnant women operated on a bariatric surgery using the biological results at T1, T2, T3. Retrospective collection of the results of the biological assessment prescribed in the three trimesters (including vitamins, trace elements) for the group of women operated on bariatric surgery an average of 7,20 and 33 weeks
Secondary protein requirements of the pregnant woman according to the 3 groups The protein requirement of the patients is determined from a statistical analysis called straight line of linear regression between nitrogen balance and protein intake (g / kg / day body weight) for the population. It corresponds, according to this line, to the value for which the nitrogen balance is zero. an average of 33 weeks